IDH1 and neoplasm: MPA treatment markedly impaired tumor volume (Figure 3d,e), weight (Figure 3f), and proliferation (Figure 3g) in the IDH1T77A tumor‐bearing group; however, in IDH1 T77D mice, no significant reduction in tumor growth was observed (Figure 3d–g).